ACER THERAPEUTICS INC (ACER)
US00444P1084 - Common Stock
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.33M | 12.71M | 5.76M | 12.08M | 41.67M | |||
| Receivables | 0.00 | 5.00M | N/A | N/A | N/A | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.19M | 10.38M | 680.00K | 810.00K | 1.08M | |||
| Total Current Assets | 3.52M | 28.09M | 6.44M | 12.89M | 42.75M | |||
| Non-Current Assets | ||||||||
| PPE Net | 414.58K | 114.11K | 530.00K | 790.00K | 130.00K | |||
| Goodwill | 7.65M | 7.65M | 7.65M | 7.65M | 7.65M | |||
| Intangibles | N/A | N/A | N/A | 120.00K | 120.00K | |||
| Other Non-Current Assets | 45.68K | 406.96K | 0.00 | 20.00K | 20.00K | |||
| Total Non-Current Assets | 8.11M | 8.17M | 8.17M | 8.58M | 7.91M | |||
| TOTAL ASSETS | 11.62M | 36.26M | 14.61M | 21.47M | 50.66M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.33M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 3.68M | 2.44M | 3.87M | 2.06M | 4.44M | |||
| Accounts Payable | 3.81M | 1.41M | 1.67M | 560.00K | 1.03M | |||
| Other Current Liabilities | 9.13M | 25.26M | 600.00K | 150.00K | 100.00K | |||
| Total Current Liabilities | 18.95M | 29.11M | 6.15M | 2.77M | 5.58M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 9.29M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 145.67K | 8.87M | 240.00K | 330.00K | N/A | |||
| Total Non-Current Liabilities | 9.43M | 8.87M | 240.00K | 330.00K | 0.00 | |||
| TOTAL LIABILITIES | 28.39M | 37.98M | 6.39M | 3.10M | 5.58M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -140.75M | -114.51M | -99.14M | -76.25M | -46.83M | |||
| Additional Paid In Capital | 123.98M | 112.78M | 107.36M | 94.62M | 91.91M | |||
| Common Shares | 1.96K | 1.43K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 19.62M | 14.31M | 13.23M | 10.10M | 10.09M | |||
| Tangible Book Value per Share | -1.24 | -0.65 | 0.04 | 1.05 | 3.70 | |||
| Total Shareholders' Equity | -16.76M | -1.72M | 8.22M | 18.37M | 45.08M | |||
| TOTAL LIABILITIES AND EQUITY | 11.62M | 36.26M | 14.61M | 21.47M | 50.66M | |||
| Statistics | ||||||||
| Debt/Equity | -0.55 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 0.19 | 0.96 | 1.05 | 4.65 | 7.66 | |||
| Return On Assets (ROA) | -225.71% | -42.40% | -156.67% | -137.03% | -42.01% | |||
| Return On Equity (ROE) | N/A | N/A | -278.47% | -160.15% | -47.20% | |||
All data in USD